Open original FDA record ↗Recall record
- FDA identifier
- Z-1230-2016
- Company in FDA record
- Qiagen Sciences LLC
- FDA record creation date
- Mar 22, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for obtaining a false positive result due to the possibility of endotoxin presence.
Source facts
- Action
- QIAGEN sent an "Urgent - Notification of Market Withdrawal" dated February 2, 2016, to all affected customers. The letter identify the product the problem and the action needed to be taken by the customer. Immediately discontinue use of this lot and discard any remaining inventory. Please acknowledge receipt of this notification and actions taken by completing the information on the next page, and return to: TechService-NA@qiagen.com or fax +1-661-775-7479. QIAGEN apologizes for any inconvenience this market withdrawal has caused, and continues to take every effort possible to ensure the highest quality of product is always available to our valued customers around the globe. Please do not hesitate to contact your local QuantiFERON sales representative or customer service representative should you have any questions or concerns. For further questions, please call ( 240) 686-7500.
- Initiated
- 2016-02-02
- Root cause
- Nonconforming Material/Component
- Terminated
- 2016-08-16
- Distribution
- Worldwide Distribution - US Distribution to the state of : Georgia., and to the countries of : Austria, Belgium, Switzerland, Czech Republic, Germany, Denmark, Estonia, Spain, France, Great Britain, Ireland, Korea (South) Luxembourg, Netherlands, Poland, Portugal, Qatar, Russian (Federation), Singapore, Turkey and South Africa.
- Recall number
- Z-1230-2016
- Recall status
- Terminated
- CDRH record ID
- 143995
- FDA record created
- 2016-03-22
- Recall event number
- 73384